Furthermore, the ability of apocynin to reduce neuronal cell death, neurological impairment and mortality in the stroke studies was lost when it was administered in NOX2 knockout mice, which strongly suggests that the beneficial neural effects of apocynin are due specifically to inhibition of NOX2 NADPH oxidase [35]. The gene discussed is FMO5; the disease is stroke disorder.